BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 14024623)

  • 1. The effect of Segontin, Persantin and nitroglycerin on the coronary artery. Experimental studies with cinecoronarography.
    DAHL M; KASANEN A; PELTONEN T
    Ann Med Exp Biol Fenn; 1962; 40():423-6. PubMed ID: 14024623
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical aspects of persantin, segontin and trimanyl in the light of the results of experimental studies on the coronary circulation in dogs].
    Janicki K; Wcislo W
    Pol Tyg Lek; 1967 May; 22(21):779-81. PubMed ID: 6040998
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on the site of action of persantin, segontin and trimanyl. Their effect on the bioelectric activity of rabbit's brain.
    Janicki K; Trabka J; Gatarski J
    Pol Med J; 1970; 9(1):1816. PubMed ID: 5437035
    [No Abstract]   [Full Text] [Related]  

  • 4. [TREATMENT OF ANGINA PECTORIS WITH PERSANTIN AND SEGONTIN, 2 NEW CORONARY DILATOR AGENTS. EXPERIENCE WITH DOUBLE BLIND CONTROL].
    ROMAN O
    Rev Med Chil; 1963 Jul; 91():508-13. PubMed ID: 14084441
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of coronary insufficiency].
    NANBA H
    Sogo Rinsho; 1963 Jul; 12():1378-85. PubMed ID: 13937539
    [No Abstract]   [Full Text] [Related]  

  • 6. [On modern coronary dilators].
    KNABE J
    Mitt Dtsch Pharm Ges Pharm Ges DDR; 1963 May; 33():77-82. PubMed ID: 14041704
    [No Abstract]   [Full Text] [Related]  

  • 7. Recently introduced cardiovascular drugs under experimental test.
    KOHLER H
    Drugs Made Ger; 1963 Jun; 6():71-2. PubMed ID: 14034203
    [No Abstract]   [Full Text] [Related]  

  • 8. Persantin.
    Med Lett Drugs Ther; 1966 Apr; 8(7):27-8. PubMed ID: 4956154
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on the mode of action of prenylamine (Segontin) and other coronary dilating drugs in man.
    Schmid E; Bachmann K; Krautheim J; Heynen HP
    Indian Heart J; 1968 Apr; 20(2):133-40. PubMed ID: 5738423
    [No Abstract]   [Full Text] [Related]  

  • 10. [Review of pharmacologic data and therapeutic schemes on the subject of coronary pathology].
    PERROTTA P
    Minerva Med; 1963 Apr; 54():1165-76. PubMed ID: 13942610
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of persantin on intercoronary collateral circulation and on survival obtained during progressive coronary occlusion in in animals. Preliminary report].
    VINEBERG AM; CHARI RS; PIFARRE R; MERCIER C
    Union Med Can; 1962 Oct; 91():1068-79. PubMed ID: 14010456
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparison of phenylpropyl-diphenylpropyl-amine with other drugs for the treatment of coronary angina and influence on the consumption of nitroglycerin derivatives].
    DI LORENZO S; COSTAGLIOLA A
    Minerva Med; 1963 Apr; 54():1188-93. PubMed ID: 14027552
    [No Abstract]   [Full Text] [Related]  

  • 13. [Action of Persantin on the coronary circulation].
    Brugger A; Lluch S; Marco V; Esplugues J
    Rev Clin Esp; 1965 Sep; 98(6):401-4. PubMed ID: 5865268
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of nitroprusside and nitroglycerin on coronary blood flow in stenotic arteries: study in patients with single-vessel coronary artery disease.
    Gatzov P; Voudris V; Skoularikis J; Gentchev G; Manginas A; Cokkinos DV
    J Invasive Cardiol; 2008 Aug; 20(8):391-5. PubMed ID: 18688061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [PHENYL-PROPYL-DIPHENYL-PROPYL-AMINE (SEGONTIN) IN TREATMENT OF SYNDROMES DUE TO CORONARY INSUFFICIENCY IN PATIENTS OVER SEVENTY].
    FRANZINI C; TURRI C; MONTEROSSO A
    Minerva Cardioangiol; 1964 Dec; 12():515-27. PubMed ID: 14269033
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment with phenyl-propyl-diphenyl-propyl-amine (Segontin Hoechst) in coronary disease].
    DOBREANU-ENESCU V; TEODORINI S; HARNAGEA P
    Stud Cercet Med Interna; 1963; 4():243-53. PubMed ID: 14028230
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical observations on the use of a new synthetic agent (3,3-diphenyl-N-(alpha-methylphenethyl)-propylamine, Segontin) in coronary insufficiency syndromes].
    CESARI L
    Gazz Int Med Chir; 1962 Sep; 66():1994-2004. PubMed ID: 14019763
    [No Abstract]   [Full Text] [Related]  

  • 18. [3'-phenyl-propyl-(2')]-1, 1-diphenyl-propyl-(3)-amine (Segontin).
    MALTEZ JS
    J Med (Oporto); 1963 Jan; 50():189-202. PubMed ID: 13932641
    [No Abstract]   [Full Text] [Related]  

  • 19. [Apropos of the use of "Segontin" in coronary patients].
    Arnoux E; Boutin C; Ohresser P; Olmer M; Luccioni L; Bory M
    Arch Med Gen Trop; 1965; 42(4):203-16. PubMed ID: 5846359
    [No Abstract]   [Full Text] [Related]  

  • 20. Prenylamine ("Segontin") in angina of effort.
    ANDERSON DE
    Med J Aust; 1963 Feb; 50(1)():149-50. PubMed ID: 14012827
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.